Ind-Swift Laboratories Ltd.

View in App
85.05 -0.45 ▼-0.5%

25 September 2023, 04:01:00 PM
Volume: 11,444

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswiftlabs.com
Market Cap 508.15 Cr.
Enterprise Value(EV) 1,341.94 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 7.78 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 10.93 Trailing Twelve Months Ending 2023-06
Industry PE 37.43 Trailing Twelve Months Ending 2023-06
Book Value / Share 87.19 Trailing Twelve Months Ending 2023-06
Price to Book Value 0.98 Calculated using Price: 85.05
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 5.91 Cr. 59,086,860 Shares
FaceValue 10
About Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry.

Ind-Swift Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ind-Swift Laboratories Ltd. Performance

View details >>
1 Day
-0.53%
1 Week
-6.59%
1 Month
-4.99%
3 Month
+7.99%
6 Month
+44.94%
1 Year
+43.42%
2 Year
+33.31%
5 Year
+30.65%
10 Year
+169.57%

Ind-Swift Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -36.36 -23.11 -15.89 7.89 8.99 -5.56 -0.78 -0.54 10.61
Return on Capital Employed (%) -1.52 1.40 2.19 4.59 9.25 5.97 8.31 7.88 13.25
Return on Assets (%) -5.22 -2.65 -1.86 1.11 1.53 -1.17 -0.18 -0.12 2.70

Ind-Swift Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 725 595 517 531 553 588 641 604 601 682
Non Curr. Liab. 983 811 717 495 438 901 828 840 814 741
Curr. Liab. 630 833 951 1,005 936 356 323 315 334 371
Minority Int. 0 0
Equity & Liab. 2,339 2,239 2,185 2,031 1,927 1,845 1,792 1,758 1,749 1,794
Non Curr. Assets 1,350 1,319 1,264 1,202 1,088 1,009 929 814 674 630
Curr. Assets 989 920 922 829 839 836 863 942 1,073 1,163
Misc. Exp. not W/O
Total Assets 2,339 2,239 2,185 2,031 1,927 1,845 1,792 1,758 1,749 1,794

Ind-Swift Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 660 653 697 763 757 780 891 1,039 1,207 1,237
Other Income 22 16 23 26 37 33 23 44 34 32
Total Income 683 669 720 788 794 813 914 1,082 1,241 1,269
Total Expenditure -572 -546 -591 -628 -630 -636 -709 -843 -978 -1,000
PBIDT 111 123 129 160 163 177 206 239 263 269
Interest -117 -106 -90 -35 -92 -107 -100 -96 -92 -89
Depreciation -84 -85 -88 -87 -104 -90 -87 -131 -57 -55
Taxation 24 24 16 -14 -21 -1 -21 -15 -39 -53
Exceptional Items -53 -15 -5 -2 83 -27 -27
PAT -119 -59 -39 22 29 -21 -3 -2 48 46
Minority Interest
Share Associate 0 0
Other Related Items
Consolidated Net Profit -119 -59 -39 22 29 -21 -3 -2 48 46
Adjusted EPS -29 -14 -9 5 6 -4 -1 0 8 8

Ind-Swift Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 66 98 79 96 73 -64 125 135 150 195
Cash Fr. Inv. -27 -36 -30 -31 -17 -12 -9 -10 5 -13
Cash Fr. Finan. -38 -64 -48 -69 -62 100 -133 -124 -141 -186
Net Change 0 -1 2 -4 -6 23 -17 1 14 -4
Cash & Cash Eqvt 21 20 22 16 9 30 11 12 26 17

Ind-Swift Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 42.00 42.00 42.00 42.00 42.00 42.00 42.00 42.00 42.00
Public 58.00 58.00 58.00 58.00 58.00 58.00 58.00 58.00 58.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 86.87 86.87 86.87 86.81 86.84 86.84 86.84 86.84 86.84

Ind-Swift Laboratories Ltd. Announcements

View details >>
Mon, 25 Sep 2023
Outcome Of Board Meeting Held On 25Th September 2023
Disclosure under Regulation 30 regarding Scheme of arrangement for Amalgamation
Tue, 19 Sep 2023
Intimation Of Withdrawal Of Book Closure For The Purpose Of EGM
Withdrawal of Book Closure for the purpose of EGM.
Thu, 14 Sep 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Notice of EGM

Ind-Swift Laboratories Ltd. Technical Scans

View details >>
Mon, 25 Sep 2023
High Delivery Percentage High Delivery Percentage
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Month Low Close Below Last Month Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Ind-Swift Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,697.25 1,124.05 -0.7%
Divi's Laboratories Ltd. 99,021.11 3,730.05 +0.6%
Cipla Ltd. 95,166.58 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. 90,720.90 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. 73,268.35 5,095.45 +2.2%
Mankind Pharma Ltd. 69,694.38 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. 62,519.33 1,844.85 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.97 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 67.03 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 30.62 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.21 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 109.58 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 54.37 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.55 1,844.85 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 7.55 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 3.91 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.68 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.49 1,844.85 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,844.85 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,844.85 -0.3%

Ind-Swift Laboratories Ltd. FAQ's

What is Ind-Swift Lab. share price?
Can I buy Ind-Swift Lab. shares now?
What is the Market Cap of Ind-Swift Lab.?
What are the key metrics to analyse Ind-Swift Lab.?
What is the 52 Week High and Low of Ind-Swift Lab.?
What is the trend of Ind-Swift Lab. share price?